{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T04:46:43.578776+00:00","published_at":"2026-10-17T04:46:43.578776+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:3p65hs13pl35u","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:mary-j-grendell","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:ce642dfe3e076efdaac5bf8fdc70f976f8d75dbdf3846d694ff3b1eb64857e66"],"summary":"Mary J. Grendell executive of Protara Therapeutics, Inc., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12gw2sjo76qg7","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Cynthia Smith seat on Protara Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4ao5uj1xj03at","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:jane-huang-m-d","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Jane Huang, M.D. seat on Protara Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1g9q5od1koonej","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:protara-therapeutics-inc:compensation-chair","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Compensation · Chair committee of Protara Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:34bawefgm4zm","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:cynthia-smith","alpha:committee:protara-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Cynthia Smith member of Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vbm3651fm1dlh","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:barry-flannelly-pharm-d","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Barry Flannelly, Pharm.D. seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1a5z5xjekvug7","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:gregory-sargen","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Gregory Sargen seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1k2pywx1ja4d5t","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:jesse-shefferman","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Jesse Shefferman seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1riufzz175zr99","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:luke-beshar","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Luke Beshar seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4eo47i95dj9o","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:michael-solomon-ph-d","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Michael Solomon, Ph.D. seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1v8d7gv1p6ck0b","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:richard-levy-m-d","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Richard Levy, M.D. seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fvc2ny1pa7izu","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:roger-garceau-m-d","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Roger Garceau, M.D. seat on Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1y7walfuher8f","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:protara-therapeutics-inc:audit-chair","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Audit · Chair committee of Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lpizzb1rsmsvn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:gregory-sargen","alpha:committee:protara-therapeutics-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Gregory Sargen member of Audit · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gjck7xstrfu1","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:committee:protara-therapeutics-inc:audit-nominating-and-governance-chair","alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Audit; Nominating and Governance · Chair committee of Protara Therapeutics, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rfobnp1lf2533","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:43.578776+00:00","subject_ids":["alpha:person:luke-beshar","alpha:committee:protara-therapeutics-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d"],"summary":"Luke Beshar member of Audit; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:5","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barry-flannelly-pharm-d","object_label":"Barry Flannelly, Pharm.D.","object_source_name_forms":[],"value":"Barry Flannelly, Pharm.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barry-flannelly-pharm-d","name":"Barry Flannelly, Pharm.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:6","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cynthia-smith","object_label":"Cynthia Smith","object_source_name_forms":[],"value":"Cynthia Smith: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cynthia-smith","name":"Cynthia Smith"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:7","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gregory-sargen","object_label":"Gregory Sargen","object_source_name_forms":[],"value":"Gregory Sargen: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gregory-sargen","name":"Gregory Sargen"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:8","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jane-huang-m-d","object_label":"Jane Huang, M.D.","object_source_name_forms":[],"value":"Jane Huang, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jane-huang-m-d","name":"Jane Huang, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:9","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jesse-shefferman","object_label":"Jesse Shefferman","object_source_name_forms":[],"value":"Jesse Shefferman: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jesse-shefferman","name":"Jesse Shefferman"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:10","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:luke-beshar","object_label":"Luke Beshar","object_source_name_forms":[],"value":"Luke Beshar: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:luke-beshar","name":"Luke Beshar"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:11","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-solomon-ph-d","object_label":"Michael Solomon, Ph.D.","object_source_name_forms":[],"value":"Michael Solomon, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-solomon-ph-d","name":"Michael Solomon, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:12","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-levy-m-d","object_label":"Richard Levy, M.D.","object_source_name_forms":[],"value":"Richard Levy, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-levy-m-d","name":"Richard Levy, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:13","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:roger-garceau-m-d","object_label":"Roger Garceau, M.D.","object_source_name_forms":[],"value":"Roger Garceau, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:roger-garceau-m-d","name":"Roger Garceau, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-25","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:779ec97e-223b-487e-b645-a3a9f88a1bcf:leadership_role:14","subject_id":"alpha:company:779ec97e-223b-487e-b645-a3a9f88a1bcf","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:mary-j-grendell","object_label":"Mary J. Grendell","object_source_name_forms":[],"value":"Mary J. Grendell: Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:mary-j-grendell","name":"Mary J. Grendell"},"title":"Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-17T04:46:43.578776+00:00","sources":[{"id":"alpha:projection-evidence:document:ce642dfe3e076efdaac5bf8fdc70f976f8d75dbdf3846d694ff3b1eb64857e66","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TARA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026048536/ea0286228-04.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T08:57:35.807338+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:436b1d05cbd3cedd2e436645f41876bb99d84c3e889f2f05fcd47f38c1499d2d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Protara Therapeutics, Inc. DEF 14A 2025-04-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390025035568/ea0239092-01.htm","source_date":"2025-04-25","retrieved_at":"2026-04-28T23:48:01.761+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ce642dfe3e076efdaac5bf8fdc70f976f8d75dbdf3846d694ff3b1eb64857e66","identity_scope":"source_document_reference","source_type":"sec_filing","title":"TARA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026048536/ea0286228-04.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-05-16T08:57:35.807338+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.842,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.876,"cross_source_agreement":0.75,"temporal_completeness":0.714},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:43.578776+00:00","observed_at":"2026-10-17T04:46:43.578776+00:00","reviewed_at":"2026-10-17T04:46:43.578776+00:00","verified_at":"2026-10-17T04:46:43.578776+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/protara-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/protara-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}